Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome - PubMed

Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome

S F Lanes et al. J Clin Epidemiol. 1990.

Abstract

Tampon use has been identified as a major risk factor for toxic shock syndrome, although the etiologic role of tampons is not clearly understood. Two epidemiologic studies conducted to date have reported an association between tampon absorbency and risk of toxic shock syndrome. This finding is not corroborated by laboratory studies, however, which have suggested that absorbency may be a marker for other characteristics that create an environment conductive to the elaboration of toxic shock syndrome toxin 1. We used data from the previously reported Tri-state study to estimate simultaneously the effects of tampon oxygen content, absorbency and chemical composition. Although the data are sparse, oxygen content was more strongly associated with risk of toxic shock syndrome than either absorbency or chemical composition. The results suggest that it may be possible to develop a highly absorbent tampon that is not associated with a high risk of toxic shock syndrome.

Similar articles

• Toxic shock syndrome: an update.

  Reingold AL. Reingold AL. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1236-9. doi: 10.1016/s0002-9378(12)90734-6. Am J Obstet Gynecol. 1991. PMID: 1951580 Review.

• Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production.

  Schlievert PM, Blomster DA, Kelly JA. Schlievert PM, et al. Obstet Gynecol. 1984 Nov;64(5):666-71. Obstet Gynecol. 1984. PMID: 6436761

• The relationship of tampon characteristics to menstrual toxic shock syndrome.

  Berkley SF, Hightower AW, Broome CV, Reingold AL. Berkley SF, et al. JAMA. 1987 Aug 21;258(7):917-20. JAMA. 1987. PMID: 3613021

• Vaginal tampon model for toxic shock syndrome.

  Melish ME, Murata S, Fukunaga C, Frogner K, McKissick C. Melish ME, et al. Rev Infect Dis. 1989 Jan-Feb;11 Suppl 1:S238-46; discussion S246-7. doi: 10.1093/clinids/11.supplement_1.s238. Rev Infect Dis. 1989. PMID: 2928642

• Toxic shock syndrome and tampons.

  Schuchat A, Broome CV. Schuchat A, et al. Epidemiol Rev. 1991;13:99-112. doi: 10.1093/oxfordjournals.epirev.a036080. Epidemiol Rev. 1991. PMID: 1662639 Review.

Cited by

• Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.

  Kansal R, Davis C, Hansmann M, Seymour J, Parsonnet J, Modern P, Gilbert S, Kotb M. Kansal R, et al. J Clin Immunol. 2007 May;27(3):327-38. doi: 10.1007/s10875-007-9072-4. Epub 2007 Mar 6. J Clin Immunol. 2007. PMID: 17340193

• A study on the microbial quality of sealed products for feminine hygiene.

  Briancesco R, Paduano S, Semproni M, Bonadonna L. Briancesco R, et al. J Prev Med Hyg. 2018 Sep 28;59(3):E226-E229. doi: 10.15167/2421-4248/jpmh2018.59.3.920. eCollection 2018 Sep. J Prev Med Hyg. 2018. PMID: 30397679 Free PMC article.

• Device-Associated Menstrual Toxic Shock Syndrome.

  Schlievert PM, Davis CC. Schlievert PM, et al. Clin Microbiol Rev. 2020 May 27;33(3):e00032-19. doi: 10.1128/CMR.00032-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32461307 Free PMC article. Review.

MeSH terms

Substances